SCHEMBL3070064

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3063670	0.90	AR (0.52)	ARP2RY14POLBPTGDR2SLC2A1
	SCHEMBL3085330	0.89	AR (0.50)	ARPOLBPTGDR2SLC2A1GAA
	SCHEMBL27815952	0.89	AR (0.56)	ARP2RY14PTGDR2ALKBH1
	SCHEMBL3080596	0.88	AR (0.53)	ARP2RY14POLBPTGDR2MEN1
	SCHEMBL13142730	0.86	AR (0.49)	ARP2RY14POLBPTGDR2SLC2A1
	SCHEMBL3075372	0.84	AR (0.48)	ARPOLBPTGDR2
	SCHEMBL3076106	0.84	AR (0.56)	ARPOLBPTGDR2
	SCHEMBL3070156	0.83	SLC2A1 (0.53)	ARPOLBPTGDR2SLC2A1SLC2A3
	SCHEMBL3073295	0.79	AR (0.41)	ARP2RY14POLBPTGDR2MAPT
	SCHEMBL6468062	0.79	AR (1.00)	ARP2RY14POLBPTGDR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.